Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
Research To Practice | Oncology Videos · Dr. Neil Love
May 23, 202542m 34s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring a slide presentation from Dr Matthew Matasar and related discussion from Dr Carla Casulo, Dr Matasar and Dr Laurie H Sehn, including the following topics:
- EZH2 Inhibitors for Follicular Lymphoma (FL) (0:00)
- Bruton Tyrosine Kinase Inhibitors for FL (5:43)
- Anti-CD19 Antibodies for FL (9:40)
- Other Novel Agents Under Clinical Development for FL (18:50)
- Case: A woman in her early 80s with multiple comorbidities and relapsed FL (23:06)
- Case: A man in his early 40s with high-risk progressive FL that did not achieve deep remission with prior therapy (27:07)
- Case: A woman in her early 70s with rheumatoid arthritis and relapsed FL (33:46)